| (1) | 
    Ayala A, Danese MD, Ladenson PW. When to treat mild 
      hypothyroidism. Endocrinol Metab Clin North Am 2000; 29: 399-415. | 
  
   
    | (2) | 
    Tunbridge WMG, Evered DC, Hall R, et al. The spectrum 
      of thyroid disease in a community: the Whickham survey. Clin Endocrinol 
      (Oxf) 1977; 7: 481-493. | 
  
   
    | (3) | 
    Canaris GJ, Manowitz NR, Mayor GM, Ridgway EC. The Colorado 
      thyroid disease prevalence study. Arch Intern Med 2000; 160: 526-534. | 
  
   
    | (4) | 
    Danese MD, Powe NR, Sawin CT, Ladenson PW. Screening 
      for mild thyroid failure at the periodic health examination: a decision 
      and cost-effectiveness analysis. JAMA 1996; 276: 285-292. | 
  
   
    | (5) | 
    Ladenson PW, Singer PA, Ain KB, et al. American Thyroid 
      Association guidelines for detection of thyroid dysfunction. Arch Intern 
      Med 2000; 160: 1573-1575. | 
  
   
    | (6) | 
    Clinical practice guidelines for the evaluation and 
      treatment of hyperthyroidism and hypothyroidism. Jacksonville, Fla.: American 
      Association of Clinical Endocrinologists, 1996. (Accessed July 2, 2001, 
      at http://www.aace.com/clinguideindex.htm) | 
  
   
    | (7) | 
    Glenn GC, Laboratory Testing Task Force of the College 
      of American Pathologists. Practice parameter on laboratory panel testing 
      for screening and case finding in asymptomatic adults. Arch Pathol Lab Med 
      1996; 120: 929-943. | 
  
   
    | (8) | 
    Periodic health examination: summary of AAFP policy 
      recommendations and age charts, revision 4.0. Kansas City, Mo.: American 
      Academy of Family Physicians, 2000. | 
  
   
    | (9) | 
    Precis: an update in obstetrics and gynecology: primary 
      & preventive care. Washington, D.C.: American College of Obstetrics and 
      Gynecology, 1998: 3-15. | 
  
   
    | (10) | 
    American College of Physicians. Screening for thyroid 
      disease. Ann Intern Med 1998; 129: 141-143. | 
  
   
    | (11) | 
    Preventive Services Task Force. Guide to clinical preventive 
      services. 2nd ed. Baltimore: Williams & Wilkins, 1996: 209-18. | 
  
   
    | (12) | 
    Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN. 
      Consensus statement for good practice and audit measures in the management 
      of hypothyroidism and hyperthyroidism. BMJ 1996; 313: 539-544. | 
  
   
    | (13) | 
    Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid 
      deficiency during pregnancy and subsequent neuropsychological development 
      of the child. N Engl J Med 1999; 341: 549-555. | 
  
   
    | (14) | 
    Allan WC, Haddow JE, Palomaki GE, et al. Maternal thyroid 
      deficiency and pregnancy complications: implications for population screening. 
      J Med Screen 2000; 7: 127-130. | 
  
   
    | (15) | 
    Leung AS, Miller LK, Koonings PP, Montoro M, Mestman 
      JH. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 1993; 81: 
      349-353. | 
  
   
    | (16) | 
    Lincoln SR, Ke RW, Kutteh WH. Screening for hypothyroidism 
      in infertile women. J Reprod Med 1999; 44: 455-457. | 
  
   
    | (17) | 
    Vanderpump MP, Tunbridge WM, French JM, et al. The incidence 
      of thyroid disorders in the community: a twenty-year follow-up of the Whickham 
      survey. Clin Endocrinol (Oxf) 1995; 43: 55-68. | 
  
   
    | (18) | 
    Helfand M, Redfern CC. Screening for thyroid disease: 
      an update. Ann Intern Med 1998; 129: 144-158. [Erratum, Ann Intern Med 1999; 
      130: 246.] | 
  
   
    | (19) | 
    Kumana CR, Cheung BMY, Lauder IJ. Gauging the impact 
      of statins using number needed to treat. JAMA 1999; 282: 1899-1901. | 
  
   
    | (20) | 
    Elder J, McClelland A, O'Reilly DS, Packard CJ, Series 
      JJ, Shepherd J. The relationship between serum cholesterol and serum thyrotropin, 
      thyroxine and tri-iodothyronine concentrations in suspected hypothyroidism. 
      Ann Clin Biochem 1990; 27: 110-113. | 
  
   
    | (21) | 
    Staub J-J, Althaus BU, Engler H, et al. Spectrum of 
      subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, 
      and thyroid reserve, and metabolic impact on peripheral target tissues. 
      Am J Med 1992; 92: 631-642. | 
  
   
    | (22) | 
    Danese MD, Ladenson PW, Meinert CL, Powe NR. Effect 
      of thyroxine therapy on serum lipoproteins in patients with mild thyroid 
      failure: a quantitative review of the literature. J Clin Endocrinol Metab 
      2000; 85: 2993-3001. | 
  
   
    | (23) | 
    Diekman T, Lansberg PJ, Kastelein JJ, Wiersinga WM. 
      Prevalence and correction of hypothyroidism in a large cohort of patients 
      referred for dyslipidemia. Arch Intern Med 1995; 155: 1490-1495. | 
  
   
    | (24) | 
    Vanderpump MP, Tunbridge WMG, French JM, et al. The 
      development of ischemic heart disease in relation to autoimmune thyroid 
      disease in a 20-year follow-up study of an English community. Thyroid 1996; 
      6: 155-160. | 
  
   
    | (25) | 
    Hak AE, Pols HAP, Visser TJ, Drexhage HA, Hofman A, 
      Witteman JC. Subclinical hypothyroidism is an independent risk factor for 
      atherosclerosis and myocardial infarction in elderly women: the Rotterdam 
      Study. Ann Intern Med 2000; 132: 270-278. | 
  
   
    | (26) | 
    Zulewski H, Muller B, Exer P, Miserez AR, Staub JJ. 
      Estimation of tissue hypothyroidism by a new clinical score: evaluation 
      of patients with various grades of hypothyroidism and controls. J Clin Endocrinol 
      Metab 1997; 82: 771-776. | 
  
   
    | (27) | 
    Lindeman RD, Schade DS, LaRue A, et al. Subclinical 
      hypothyroidism in a biethnic, urban community. J Am Geriatr Soc 1999; 47: 
      703-709. | 
  
   
    | (28) | 
    Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. 
      L-thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled 
      trial. Ann Intern Med 1984; 101: 18-24. | 
  
   
    | (29) | 
    Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg 
      P-A, Lindstedt G. A double-blind cross-over 12-month study of L-thyroxine 
      treatment of women with "subclinical" hypothyroidism. Clin Endocrinol (Oxf) 
      1988; 29: 63-75. | 
  
   
    | (30) | 
    Jaeschke R, Guyatt G, Gerstein H, et al. Does treatment 
      with L-thyroxine influence health status in middle-aged and older adults 
      with subclinical hypothyroidism? J Gen Intern Med 1996; 11: 744-749. | 
  
   
    | (31) | 
    Kong WM, Sheikh M, Lumb P, et al. A randomized controlled 
      trial of thyroxine treatment in mild subclinical hypothyroidism. In: Program 
      & abstracts: the Endocrine Society's 82nd annual meeting, Toronto, June 
      21-24, 2000. Bethesda, Md.: Endocrine Society Press, 2000: 597. abstract. | 
  
   
    | (32) | 
    Meier C, Roth CB, Huber G, Guglielmetti M, Huber P, 
      Staub JJ. Clinical and metabolic effects of thyroxine replacement in patients 
      with mild thyroid failure: results from a double-blind placebo-controlled 
      study. In: Program & abstracts: the Endocrine Society's 82nd annual meeting, 
      Toronto, June 21-24, 2000. Bethesda, Md.: Endocrine Society Press, 2000: 
      573. abstract. | 
  
   
    | (33) | 
    Monzani F, Del Guerra P, Caraccio N, et al. Subclinical hypothyroidism: 
      neurobehavioral features and beneficial effect of L-thyroxine treatment. 
      Clin Investig 1993; 71: 367-371. | 
  
   
    | (34) | 
    Manciet G, Dartigues JF, Decamps A, et al. The PAQUID 
      survey and correlates of subclinical hypothyroidism in elderly community 
      residents in the southwest of France. Age Aging 1995; 24: 235-41. | 
  
   
    | (35) | 
    Baldini IM, Vita A, Mauri MC, et al. Psychopathological and cognitive 
      features in subclinical hypothyroidism. Prog Neuropsychopharmacol Biol Psychiatry 
      1997; 21: 925-935. | 
  
   
    | (36) | 
    Centanni M, Cesareo R, Verallo O, et al. Reversible 
      increase of intraocular pressure in subclinical hypothyroid patients. Eur 
      J Endocrinol 1997; 136: 595-598. | 
  
   
    | (37) | 
    Biondi B, Fazio S, Palmieri EA, et al. Left ventricular diastolic dysfunction 
      in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 1999; 
      84: 2064-2067. | 
  
   
    | (38) | 
    Misiunas A, Niepomniszcze H, Ravera B, Faraj G, Faure 
      E. Peripheral neuropathy in subclinical hypothyroidism. Thyroid 1995; 5: 
      283-286. | 
  
   
    | (39) | 
    Marqusee E, Haden ST, Utiger RD. Subclinical thyrotoxicosis. Endocrinol 
      Metab Clin North Am 1998; 27: 37-49. | 
  
   
    | (40) | 
    Bona M, Santini F, Rivolta G, Grossi E, Grilli R. Cost-effectiveness 
      of screening for subclinical hypothyroidism in the elderly: a decision-analytical 
      model. Pharmacoeconomics 1998; 14: 209-216. | 
  
   
    | (41) | 
    Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Is neuropsychological 
      development related to maternal hypothyroidism or to maternal hypothyroxinemia? 
      J Clin Endocrinol Metab 2000; 85: 3975-3987. | 
  
   
    | (42) | 
    Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines 
      for patients with hyperthyroidism and hypothyroidism. JAMA 1995; 273: 808-812. | 
  
   
    | (43) | 
    Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and 
      follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in 
      the United Kingdom. Clin Endocrinol (Oxf) 1991; 34: 77-83. | 
  
   
    | (44) | 
    Weetman AP. Hypothyroidism: screening and subclinical 
      disease. BMJ 1997; 314: 1175-1178. |